Novo Nordisk Charts Signal Weakness Amid Wegovy Warning, Expert Says ‘Could’ve Played Out VERY Differently If They Had Embraced $HIMS’

All NewsJuly 30, 2025

Novo Nordisk’s technical chart is displaying a largely bearish trend amid a profit warning tied to its blockbuster obesity drug Wegovy.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent